HEMATOLOGIC NEOPLASMS
Clinical trials for HEMATOLOGIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC NEOPLASMS trials appear
Sign up with your email to follow new studies for HEMATOLOGIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a lower drug dose make stem cell transplants safer for blood cancer patients?
Disease control OngoingThis study looks at whether a lower dose of the drug cyclophosphamide, given after a stem cell or bone marrow transplant, can help control blood cancers like leukemia, lymphoma, and multiple myeloma while causing fewer side effects. About 105 people aged 15 to 65 with high-risk b…
Matched conditions: HEMATOLOGIC NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 00:48 UTC
-
Could dropping one drug make stem cell transplants safer and simpler?
Disease control OngoingThis study looks at whether it is safe to skip one immune-suppressing drug (MMF) after a stem cell transplant for blood cancers. About 60 adults will receive the standard transplant and then take only two drugs (cyclophosphamide and tacrolimus) instead of the usual three. The goa…
Matched conditions: HEMATOLOGIC NEOPLASMS
Phase: PHASE2 • Sponsor: Ronald Paquette • Aim: Disease control
Last updated May 14, 2026 12:03 UTC